Skip to Main ContentSkip to FooterSkip to Search

Drug Manufacturing in a Time of Coronavirus

Summary: The COVID-19 pandemic has roiled R&D plans, created new priorities overnight and generally forced a major shift in many global manufacturing operations. This is an unprecedented…